Robert Stein, MBBS, PhD, discusses the background and design of the OPTIMA trial of test-directed chemotherapy in ER-positive, HER2-negative early breast cancer.
Robert Stein, MBBS, PhD
Advertisement
Robert Stein, MBBS, PhD, is an honorary consultant oncologist at University College London (UCL) Hospitals and a professor of breast oncology at UCL Cancer Institute.
Articles by Robert Stein, MBBS, PhD
Robert Stein, MBBS, PhD, discusses the data from the OPTIMA trial in ER+, HER2-negative early breast cancer and the trial's key clinical implications.
Robert Stein, MBBS, PhD, discusses data from the OPTIMA trial in ER+, HER2– early breast cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daraxonrasib for Metastatic Pancreatic Ductal Adenocarcinoma
2
Dr Reiss Binder on the FDA Approval of Daraxonrasib for Metastatic PDAC
3
ASCO Issues Warning Regarding Ifosfamide Shortage for Cancer Care
4
Dr Ayanambakkam on the Safety of Darlifarnib Plus Cabozantinib in RCC KD
5